RU2012143852A - MEANS FOR CUPPING ALCOHOLIC ABSTINENT SYNDROME - Google Patents

MEANS FOR CUPPING ALCOHOLIC ABSTINENT SYNDROME Download PDF

Info

Publication number
RU2012143852A
RU2012143852A RU2012143852/15A RU2012143852A RU2012143852A RU 2012143852 A RU2012143852 A RU 2012143852A RU 2012143852/15 A RU2012143852/15 A RU 2012143852/15A RU 2012143852 A RU2012143852 A RU 2012143852A RU 2012143852 A RU2012143852 A RU 2012143852A
Authority
RU
Russia
Prior art keywords
cupping
alcoholic
prolyl
syndrome
drug
Prior art date
Application number
RU2012143852/15A
Other languages
Russian (ru)
Other versions
RU2521226C2 (en
Inventor
Сергей Борисович Середенин
Лариса Геннадьевна Колик
Анна Владимировна Надорова
Марина Михайловна Козловская
Original Assignee
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" РАМН filed Critical Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" РАМН
Priority to RU2012143852/15A priority Critical patent/RU2521226C2/en
Publication of RU2012143852A publication Critical patent/RU2012143852A/en
Application granted granted Critical
Publication of RU2521226C2 publication Critical patent/RU2521226C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Применение треонил-лизил-пролил-аргинил-пролил-глицил-пролил-диацетата (препарат селанк) в качестве средства, купирующего алкогольный абстинентный синдром.The use of threonyl-lysyl-prolyl-arginyl-prolyl-glycyl-prolyl-diacetate (Selank drug) as a drug that relieves alcohol withdrawal syndrome.

Claims (1)

Применение треонил-лизил-пролил-аргинил-пролил-глицил-пролил-диацетата (препарат селанк) в качестве средства, купирующего алкогольный абстинентный синдром. The use of threonyl-lysyl-prolyl-arginyl-prolyl-glycyl-prolyl-diacetate (Selank drug) as a drug that relieves alcohol withdrawal syndrome.
RU2012143852/15A 2012-10-15 2012-10-15 Agent for managing alcohol abstinence syndrome RU2521226C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012143852/15A RU2521226C2 (en) 2012-10-15 2012-10-15 Agent for managing alcohol abstinence syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012143852/15A RU2521226C2 (en) 2012-10-15 2012-10-15 Agent for managing alcohol abstinence syndrome

Publications (2)

Publication Number Publication Date
RU2012143852A true RU2012143852A (en) 2014-04-20
RU2521226C2 RU2521226C2 (en) 2014-06-27

Family

ID=50480554

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012143852/15A RU2521226C2 (en) 2012-10-15 2012-10-15 Agent for managing alcohol abstinence syndrome

Country Status (1)

Country Link
RU (1) RU2521226C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2629832C1 (en) * 2016-11-14 2017-09-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Application of thr-lys-pro-arg-pro-gly-pro peptide (selank) for hepatoprotective impact in chronic emotional-pain stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1124544C (en) * 1983-06-30 1995-01-09 Институт молекулярной генетики РАН Heptapeptide possessing properties of psychostimulator of prolonged action with immunotropic activity
RU2155065C1 (en) * 1999-04-23 2000-08-27 Институт молекулярной генетики РАН Anxiolytic agent and pharmaceutical composition with anxiolytic effect

Also Published As

Publication number Publication date
RU2521226C2 (en) 2014-06-27

Similar Documents

Publication Publication Date Title
CY1124431T1 (en) SYRINGE
CY1119798T1 (en) FORM IV IV Hydrochloride Ibabradine
IN2015DN01035A (en)
TR201821285T4 (en) Pharmaceutical formulations containing a CCR3 antagonist.
BR112015003259A2 (en) compound, pharmaceutical composition, and vaccine composition.
UY34654A (en) BETA-SECRETASA INHIBITORS
UY34582A (en) ANTI-CXCR3 ANTIBODIES
CL2014003283A1 (en) Pharmaceutical formulation
CO6920289A2 (en) Topical ophthalmic pharmaceutical composition containing regorafenib.
IT1397416B1 (en) TABLE WITH TELESCOPIC-TILTING BASE.
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
IN2013MU01985A (en)
BR112014032501A2 (en) compound and pharmaceutical composition.
UY4242Q (en) TABLE
RU2012143852A (en) MEANS FOR CUPPING ALCOHOLIC ABSTINENT SYNDROME
FR2997152B1 (en) PNEUMATIC SUPPORT.
ITTO20111170A1 (en) STRUCTURE FOR THE SUPPORT OF AN ELBOW TREE.
UY34320A (en) 2- (CROMAN-6-ILOXI) -TIAZOLES SUBSTITUTED AND ITS USE AS PHARMACEUTICAL PRODUCTS.
BR112013027390A2 (en) pharmaceutical formulation
FI20126169A (en) The drug delivery system
RU2014118884A (en) MEANS FOR REDUCING ALCOHOL MOTIVATION WITH ALCOHOL DEPENDENCE
BR112016007306A2 (en) use of odiparcil in the treatment of mucopolysaccharidosis
WO2014188334A3 (en) Process for preparation of alogliptin
ES1077581Y (en) Table for domestic cultivation.
CY1124956T1 (en) SYRINGE

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner